indacaterol
Generic: INDACATEROL MALEATE·Brand: ARCAPTA NEOHALER
indacaterol: developed by 1 company · 1 FDA decision.
indacaterol evidence translation
What we can confirm
1 FDA record
What it means
Source-backed records connect indacaterol to NVS; that link alone does not prove the drug works.
What to watch
Watch for new trials or company disclosures after the FDA record.
BioSniper AIPage evidence connected
Prepared research question
How could indacaterol → NVS affect its developer, and what evidence supports the link?
Run cited research
Traceable citations · Unknowns marked
Development Pipeline (2)
| Company | Phase |
|---|---|
| Novartis AG (NVS) | Approved |
| Novartis AG (NVS) | Approved |
FDA Decisions1 records
Frequently asked questions
Who is developing indacaterol?
indacaterol is being developed by Novartis AG.
What is indacaterol's latest FDA decision?
The most recent tracked FDA decision for indacaterol is Approval, dated July 1, 2011.